12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Allerject epinephrine auto-injector regulatory update

Sanofi said Canada approved Allerject epinephrine auto-injector for the emergency treatment of severe, life-threatening allergic reaction in at-risk patients. The pharma plans...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >